Versant Vantage I, L.P.

CIK 1765253 · last filed 2025-09-18

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$176.02M

Companies

7

Total Filings

12

Lifetime Open-Market Net

-$113.67M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LAVA Therapeutics NV (LVTX) Delisted 10%+ Owner 3,358,920 $1.74 $5.84M -$15.01M 1 2025-09-18
GLUE 10%+ Owner 8,355,156 $18.23 $152.36M -$20.43M 1 2024-09-13
BDTX 10%+ Owner 4,107,283 $1.75 $7.19M -$10.78M 5 2024-08-30
Oyster Point Pharma, Inc. (OYST) Delisted 10%+ Owner 2,243,406 $11.17 $25.06M -$73.45M 1 2021-10-20
Repare Therapeutics Inc. (RPTX) Delisted 10%+ Owner 2,825,662 $2.65 $7.49M $0 2 2021-08-09
ALGS 10%+ Owner 3,092,339 $5.28 $16.33M $6.00M 1 2020-10-20
APRE 10%+ Owner 216,669 $0.69 $148.7K $0 1 2020-05-20

Recent Filings · Page 2 of 2

12 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-07-29 BDTX Other (J) −1,316,868 $0 EDGAR
2020-05-20 APRE Other (J) −349,992 $0 EDGAR
Showing 1112 of 12
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.